| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2021 | Leila Alland81 | Chief Medical Officer | Sale+OE | 4,000 | $32.30 | $129,213.11 | - | -7.2% | -49.8% | |
| Jun 28, 2021 | David Henry Mack73 | President and CEO | Sale+OE | 204 | $35.53 | $7,248.12 | -1.6% | -14.9% | -60.5% | |
| Jun 21, 2021 | Arnold J Levine79 | Director | Sell | 3,500 | $33.25 | $116,362.34 | -0.8% | -17.8% | -67.2% | |
| Jun 14, 2021 | Euclidean Capital LLC82 | 10% Owner | Sell | 66,396 | $34.01 | $2,257,954.69 | -34.3% | -16.5% | -72.3% | |
| Jun 10, 2021 | Euclidean Capital LLC82 | 10% Owner | Sell | 60,271 | $33.31 | $2,007,708.76 | -31.7% | -12.1% | -70.5% | |
| Jun 8, 2021 | Euclidean Capital LLC82 | 10% Owner | Sell | 62,445 | $33.50 | $2,091,787.14 | -32.3% | -13.0% | -69.1% | |
| Jun 7, 2021 | Leila Alland81 | Chief Medical Officer | Sale+OE | 4,000 | $33.60 | $134,386.84 | - | -13.7% | -67.5% | |
| Jun 4, 2021 | Winston Kung72 | COO, CFO | Sale+OE | 4,500 | $33.75 | $151,875.00 | -73.8% | -12.2% | -58.5% | |
| Jun 1, 2021 | Richard A. Heyman73 | Director | Sale+OE | 3,900 | $32.55 | $126,935.47 | - | -4.8% | -62.7% | |
| May 28, 2021 | Thilo Schroeder80 | Director | Sell | 5,100 | $35.80 | $182,580.00 | -0.2% | -13.3% | -55.4% |